How AI helps scientists design the next generation of medicines
Designing and developing a new medicine is an expensive, failure-prone scientific challenge. A new drug can take many years to develop, at the cost of a significant investment. And even then, most possible candidates never reach the patient. For biologic medicines, therapies made from engineered proteins rather than sy
Designing and developing a new medicine is an expensive, failure-prone scientific challenge. A new drug can take many years to develop, at the cost of a significant investment. And even then, most possible candidates never reach the patient. For biologic medicines, therapies made from engineered proteins rather than sy LaundryBrain picked this up from MIT Technology Review and scored it 80/100 for share potential. We are linking back to the original public source and keeping the spin clean: no private info, no unsupported accusations, just the public story and the chatter around it.